Insider Purchases: Inside the Buy

Tag: CEO purchase

Illustration of Primo Brands' North American hydration network with premium water brands, CEO insider buying, free cash flow metrics, and nationwide distribution infrastructure.

🚰 Primo Brands (PRMB): CEO Buys $2M Dip as an $800M Free Cash Flow Giant Emerges 💧⚡

Primo Brands isn't simply selling bottled water.

It's quietly building one of North America's largest hydration infrastructure platforms.

With repeat CEO insider buying, nearly $800 million in annual free cash flow, raised guidance, and exceptional institutional ownership, PRMB deserves a closer look.

Read entire article

Tags: BlueTriton, bottled water, CEO purchase, consumer staples, dividend stocks, Eric Foss, free cash flow, FUNanc1al, hydration, insider buying, investing, long term investing, NYSE PRMB, Poland Spring, Primo Brands, Primo Water, PRMB, stock analysis, value investing, Warren Buffett
Futuristic MRI scanner enhanced with AI data overlays and financial charts, representing GE HealthCare’s role in combining medical imaging innovation with investment potential and long-term growth.

🩺 GE HealthCare (GEHC): Insider Buying, AI Growth & a $21B Backlog Opportunity

GE HealthCare (GEHC) is quietly shaping up as a high-visibility MedTech play, combining insider buying, a $21.8B backlog, and AI-driven diagnostics. With valuation still reasonable and institutional ownership near record levels, this could be a compelling long-term compounder—if you’re patient on entry.

Read entire article

Tags: AI healthcare, AIdiagnostics, buy or sell GEHC, CEO purchase, featured-insiders, FUNanc1al, FUNanc1al Edge, FUNanc1al Investing, GE HealthCare, GEHC, GEHC stock, GEHealthCare, Healthcare innovation, Healthcare stocks, HealthcareInvesting, hub-insiders, Insider buying, InsiderBuying, Institutional ownership, Long-term investing, Medical imaging, MedTech, MedTech investing, Peter Arduini CEO, risks buying GEHC, Stock analysis 2026, Value investing, ValueStocks, why buy GEHC